OncoQuest Pharmaceuticals Inc (078590) — Cash Flow-to-Debt Ratio
OncoQuest Pharmaceuticals Inc (078590) has a Cash Flow-to-Debt Ratio of -0.07x as of March 2026, meaning its operating cash flow of ₩-1.42 Billion could theoretically repay 0% of its total liabilities (₩19.38 Billion) in one year. Explore how much of OncoQuest Pharmaceuticals Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
OncoQuest Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for OncoQuest Pharmaceuticals Inc across 10 annual periods. Also explore 078590 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for OncoQuest Pharmaceuticals Inc (2014–2025)
Year-by-year debt coverage analysis for OncoQuest Pharmaceuticals Inc. For market capitalisation and broader financial context, see how much is OncoQuest Pharmaceuticals Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | ₩485.35 Million | ₩32.66 Billion | ▼ -89.7% |
| 2024 | 0.14x | ₩3.96 Billion | ₩27.40 Billion | ▼ -86.1% |
| 2023 | 1.04x | ₩11.19 Billion | ₩10.77 Billion | ▲ +4188.5% |
| 2022 | -0.03x | ₩-236.91 Million | ₩9.33 Billion | ▲ +71.8% |
| 2019 | -0.09x | ₩-4.26 Billion | ₩47.21 Billion | ▼ -375.5% |
| 2018 | 0.03x | ₩1.44 Billion | ₩43.95 Billion | ▼ -93.0% |
| 2017 | 0.47x | ₩4.79 Billion | ₩10.21 Billion | ▼ -3.9% |
| 2016 | 0.49x | ₩3.54 Billion | ₩7.26 Billion | ▲ +20.4% |
| 2015 | 0.41x | ₩2.79 Billion | ₩6.89 Billion | ▲ +283.5% |
| 2014 | 0.11x | ₩1.02 Billion | ₩9.61 Billion | — |